Co-delivery of paclitaxel and tanespimycin in lipid nanoparticles enhanced anti-gastric-tumor effect in vitro and in vivo

Effective use of nanocarriers as drug delivery systems for the treatment of selected tumors

(2017) Fakhar ud Din et al.   International Journal of Nanomedicine

Intracellular uptake of etoposide-loaded solid lipid nanoparticles induces an enhancing inhibitory effect on gastric cancer through mitochondria-mediated apoptosis pathway

(2014) Jiao Wang et al.   International Journal of Nanomedicine

Improving Conventional Enhanced Permeability and Retention (EPR) Effects; What Is the Appropriate Target?

(2014) Hisataka Kobayashi et al.   Theranostics

High Expression of Heat Shock Protein 90 Is Associated with Tumor Aggressiveness and Poor Prognosis in Patients with Advanced Gastric Cancer

(2013) Jiahong Wang et al.   PLoS One

Hsp90 inhibitors and drug resistance in cancer: The potential benefits of combination therapies of Hsp90 inhibitors and other anti-cancer drugs

(2011) Xiangyi Lu et al.   BIOCHEMICAL PHARMACOLOGY

Paclitaxel chemotherapy for the treatment of gastric cancer

(2009) Junichi Sakamoto et al.   Gastric Cancer

Molecular mechanisms of oxidative stress resistance induced by resveratrol: Specific and progressive induction of MnSOD

(2008) Ellen L. Robb et al.   BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS

Taxanes, microtubules and chemoresistant breast cancer

(2007) Barbara T. McGrogan et al.   BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER